Because of NF-κB's central role in numerous cancer-related processes and involvement in risk of others cancers [23-26], we hypothesized that inherited variation in the genes encoding the key inhibitors IκBα and IκBβ (NFKBIA and NFKBIB, respectively) is associated with ovarian cancer risk. The gene discussed is NFKBIA; the disease is cancer.